Robert Grubb to Female
This is a "connection" page, showing publications Robert Grubb has written about Female.
Connection Strength
0.326
-
Screening for cancer: lessons learned from the prostate, lung, colorectal, and ovarian cancer screening trial. Eur Urol. 2015 Oct; 68(4):545-6.
Score: 0.027
-
Reply: Left-sided and duplicate inferior vena cava: a case series and review. Clin Anat. 2014 Oct; 27(7):948-9.
Score: 0.025
-
Intravesical bacille Calmette-Gu?rin therapy for non-muscle-invasive bladder cancer: effects of concurrent statin therapy. J Am Coll Surg. 2009 Aug; 209(2):248-53.
Score: 0.018
-
Hereditary leiomyomatosis and renal cell cancer: a syndrome associated with an aggressive form of inherited renal cancer. J Urol. 2007 Jun; 177(6):2074-9; discussion 2079-80.
Score: 0.015
-
Highlights from the Society of Urologic Oncology, 5th Annual Meeting, December 3-4, 2004, Bethesda, Maryland, United States of America. J Urol. 2005 Dec; 174(6):2330-3.
Score: 0.014
-
Transitional cell carcinoma of the renal pelvis associated with hypercalcemia in a patient with autosomal dominant polycystic kidney disease. Urology. 2004 Apr; 63(4):778-80.
Score: 0.012
-
Use of titanium staples during upper tract laparoscopic reconstructive surgery: initial experience. J Urol. 2002 Oct; 168(4 Pt 1):1366-9.
Score: 0.011
-
Recurrent Hemispheric Stroke Syndromes in Symptomatic Atherosclerotic Internal Carotid Artery Occlusions: The Carotid Occlusion Surgery Study Randomized Trial. Neurosurgery. 2020 07 01; 87(1):137-141.
Score: 0.010
-
Effectiveness of postoperative radiotherapy after radical cystectomy for locally advanced bladder cancer. Cancer Med. 2019 07; 8(8):3698-3709.
Score: 0.009
-
Intravesical rAd-IFNa/Syn3 for Patients With High-Grade, Bacillus Calmette-Guerin-Refractory or Relapsed Non-Muscle-Invasive Bladder Cancer: A Phase II Randomized Study. J Clin Oncol. 2017 Oct 20; 35(30):3410-3416.
Score: 0.008
-
Radiation Therapy for Residual or Recurrent Atypical Meningioma: The Effects of Modality, Timing, and Tumor Pathology on Long-Term Outcomes. Neurosurgery. 2016 Jul; 79(1):23-32.
Score: 0.007
-
Divergent viral presentation among human tumors and adjacent normal tissues. Sci Rep. 2016 06 24; 6:28294.
Score: 0.007
-
Identification of a novel susceptibility locus at 13q34 and refinement of the 20p12.2 region as a multi-signal locus associated with bladder cancer risk in individuals of European ancestry. Hum Mol Genet. 2016 Mar 15; 25(6):1203-14.
Score: 0.007
-
Analysis of Heritability and Shared Heritability Based on Genome-Wide Association Studies for Thirteen Cancer Types. J Natl Cancer Inst. 2015 Dec; 107(12):djv279.
Score: 0.007
-
Management of atypical cranial meningiomas, part 1: predictors of recurrence and the role of adjuvant radiation after gross total resection. Neurosurgery. 2014 Oct; 75(4):347-54; discussion 354-5; quiz 355.
Score: 0.006
-
Management of atypical cranial meningiomas, part 2: predictors of progression and the role of adjuvant radiation after subtotal resection. Neurosurgery. 2014 Oct; 75(4):356-63; discussion 363.
Score: 0.006
-
Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33. Hum Mol Genet. 2014 Dec 15; 23(24):6616-33.
Score: 0.006
-
Efficacy of robot-assisted radical cystectomy (RARC) in advanced bladder cancer: results from the International Radical Cystectomy Consortium (IRCC). BJU Int. 2014 Jul; 114(1):98-103.
Score: 0.006
-
Randomized Evaluation of Carotid Occlusion and Neurocognition (RECON) trial: main results. Neurology. 2014 Mar 04; 82(9):744-51.
Score: 0.006
-
Codeletions at 1p and 19q predict a lower risk of pseudoprogression in oligodendrogliomas and mixed oligoastrocytomas. Neuro Oncol. 2014 Jan; 16(1):123-30.
Score: 0.006
-
The safety of aeroplane travel in patients with symptomatic carotid occlusion. J Neurol Neurosurg Psychiatry. 2014 Apr; 85(4):435-7.
Score: 0.006
-
Predicting risk of bladder cancer using clinical and demographic information from prostate, lung, colorectal, and ovarian cancer screening trial participants. Cancer Epidemiol Biomarkers Prev. 2013 Dec; 22(12):2241-9.
Score: 0.006
-
Biopsy of the superficial cortex: predictors of effectiveness and outcomes. Neurosurgery. 2013 Aug; 73(2):224-31; discussion 231-2; quiz 232.
Score: 0.006
-
Reproductive factors and kidney cancer risk in 2 US cohort studies, 1993-2010. Am J Epidemiol. 2013 Jun 15; 177(12):1368-77.
Score: 0.006
-
Association between race and follow-up diagnostic care after a positive prostate cancer screening test in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer. 2013 Jun 15; 119(12):2223-9.
Score: 0.006
-
Common genetic polymorphisms modify the effect of smoking on absolute risk of bladder cancer. Cancer Res. 2013 Apr 01; 73(7):2211-20.
Score: 0.006
-
Adenocarcinoma in an ileal conduit. J Urol. 2013 Feb; 189(2):697-8.
Score: 0.006
-
Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up. J Natl Cancer Inst. 2012 Jan 18; 104(2):125-32.
Score: 0.005
-
The chromosome 2p21 region harbors a complex genetic architecture for association with risk for renal cell carcinoma. Hum Mol Genet. 2012 Mar 01; 21(5):1190-200.
Score: 0.005
-
Population based analysis of the increasing incidence of kidney cancer in the United States: evaluation of age specific trends from 1975 to 2006. J Urol. 2012 Jan; 187(1):32-8.
Score: 0.005
-
Early oncologic outcomes of robotic vs. open radical cystectomy for urothelial cancer. Urol Oncol. 2013 Aug; 31(6):894-8.
Score: 0.005
-
Positive margin during partial nephrectomy: does cancer remain in the renal remnant? Urology. 2011 Jun; 77(6):1400-3.
Score: 0.005
-
A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci. Nat Genet. 2010 Nov; 42(11):978-84.
Score: 0.005
-
Percent microscopic tumor necrosis and survival after curative surgery for renal cell carcinoma. J Urol. 2010 Mar; 183(3):909-14.
Score: 0.005
-
Preoperative sensorimotor mapping in brain tumor patients using spontaneous fluctuations in neuronal activity imaged with functional magnetic resonance imaging: initial experience. Neurosurgery. 2009 Dec; 65(6 Suppl):226-36.
Score: 0.005
-
Prospective study of [18F]fluorodeoxyglucose positron emission tomography/computed tomography for staging of muscle-invasive bladder carcinoma. J Clin Oncol. 2009 Sep 10; 27(26):4314-20.
Score: 0.004
-
Combined surgical resection and stereotactic radiosurgery for treatment of cerebral metastases. Surg Neurol. 2009 Mar; 71(3):280-8, disucssion 288-9.
Score: 0.004
-
Effect of normal saline bolus on cerebral blood flow in regions with low baseline flow in patients with vasospasm following subarachnoid hemorrhage. J Neurosurg. 2005 Jul; 103(1):25-30.
Score: 0.003
-
Evaluation and management of renal tumors in the Birt-Hogg-Dub? syndrome. J Urol. 2005 May; 173(5):1482-6.
Score: 0.003
-
Prostate Cancer Screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: findings from the initial screening round of a randomized trial. J Natl Cancer Inst. 2005 Mar 16; 97(6):433-8.
Score: 0.003
-
The relationship between renal tumor size and metastases in patients with von Hippel-Lindau disease. J Urol. 2004 Jul; 172(1):63-5.
Score: 0.003
-
Laparoscopic pyeloplasty for secondary ureteropelvic junction obstruction. J Urol. 2003 Jun; 169(6):2037-40.
Score: 0.003
-
Variability of cerebral blood volume and oxygen extraction: stages of cerebral haemodynamic impairment revisited. Brain. 2002 Mar; 125(Pt 3):595-607.
Score: 0.003
-
Regional cerebrovascular and metabolic effects of hyperventilation after severe traumatic brain injury. J Neurosurg. 2002 Jan; 96(1):103-8.
Score: 0.003